Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against J.&J.news2021-11-10T05:03:51+00:00November 10th, 2021|The New York Times|
Specialty Pharmacies Cater to the Blind and Those With Impaired Visionnews2021-09-21T16:28:23+00:00September 21st, 2021|The New York Times|
The Pain Wouldn’t Stop — Because Her Medication Had Been Stolennews2021-09-17T19:01:30+00:00September 17th, 2021|The New York Times|
Phony Diagnoses Hide High Rates of Drugging at Nursing Homesnews2021-09-11T16:37:07+00:00September 11th, 2021|The New York Times|
Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claimsnews2021-09-01T23:04:39+00:00September 1st, 2021|The New York Times|
Ivermectin Demand Surges Though It Doesn’t Work for Covid-19news2021-08-30T15:11:24+00:00August 30th, 2021|The New York Times|
Drug Distributors and J.&J. Reach $26 Billion Deal to End Opioids Lawsuitsnews2021-07-21T23:24:01+00:00July 21st, 2021|The New York Times|
States and Cities Near Tentative $26 Billion Deal in Opioids Casesnews2021-07-20T21:16:11+00:00July 20th, 2021|The New York Times|
How an Unproven Alzheimer’s Drug Got Approvednews2021-07-20T02:12:00+00:00July 20th, 2021|The New York Times|
Ohio Clinic Says It Won’t Administer Alzheimer’s Drug to Patientsnews2021-07-15T03:11:54+00:00July 15th, 2021|The New York Times|
